Inhaled Molgramostim Improves Pulmonary Gas Exchange and Respiratory Health-Related Quality of Life (HRQoL) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP): Results from Phase 3 IMPALA-2 Clinical Trial

Home / Inhaled Molgramostim Improves Pulmonary Gas Exchange and Respiratory Health-Related Quality of Life (HRQoL) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP): Results from Phase 3 IMPALA-2 Clinical Trial

See poster

We use cookies to give you the best online experience. By accepting, you agree to the use of cookies in accordance with our cookie policy.

I Accept I Decline